Farnum Rhonda
5 of 7 shown
The 5 most recent of 7 visible filings, newest first.
- Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS—Returned to the issuer
- Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS—Returned to the issuer
- Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS—Returned to the issuer
- Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS$113,397Open-market sale
- Theravance Biopharma, Inc. SVP, COMM & MEDICAL AFFAIRS$56,690Open-market sale